Bayer AG Stock price

Equities

BAYN

DE000BAY0017

Pharmaceuticals

Real-time Estimate Tradegate 07:28:40 2024-03-28 am EDT 5-day change 1st Jan Change
28.52 EUR +0.36% Intraday chart for Bayer AG +7.80% -15.12%
Sales 2024 * 47.28B 51.06B Sales 2025 * 48.21B 52.05B Capitalization 27.92B 30.15B
Net income 2024 * 2.4B 2.59B Net income 2025 * 3.31B 3.57B EV / Sales 2024 * 1.29 x
Net Debt 2024 * 33.04B 35.67B Net Debt 2025 * 29.95B 32.35B EV / Sales 2025 * 1.2 x
P/E ratio 2024 *
11.1 x
P/E ratio 2025 *
8.33 x
Employees 96,931
Yield 2024 *
0.63%
Yield 2025 *
2%
Free-Float 99.97%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.46%
1 week+7.84%
Current month+1.66%
1 month-0.02%
3 months-14.74%
6 months-37.03%
Current year-15.09%
More quotes
1 week
26.31
Extreme 26.31
28.60
1 month
24.96
Extreme 24.96
28.93
Current year
24.96
Extreme 24.96
36.09
1 year
24.96
Extreme 24.96
61.91
3 years
24.96
Extreme 24.96
67.99
5 years
24.96
Extreme 24.96
78.34
10 years
24.96
Extreme 24.96
146.45
More quotes
Managers TitleAgeSince
Chief Executive Officer 57 23-03-31
Director of Finance/CFO 54 18-04-25
Chief Tech/Sci/R&D Officer 55 20-03-31
Members of the board TitleAgeSince
Director/Board Member 68 17-03-31
Director/Board Member 68 17-03-31
Director/Board Member 68 21-03-31
More insiders
Date Price Change Volume
24-03-28 28.55 +0.46% 1 163 260
24-03-27 28.42 +4.05% 5,618,319
24-03-26 27.32 +1.77% 4,021,884
24-03-25 26.84 +0.36% 3,904,010
24-03-22 26.74 +1.00% 4,290,025

Delayed Quote Xetra, March 28, 2024 at 04:01 am EDT

More quotes
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows: - agrochemicals (49.6%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (37.9%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.; - OTC products and nutritional supplements (12%); - other (0.5%). Net sales are distributed geographically as follows: Germany (4.9%), Switzerland (1.2%), Europe/Middle East/Africa (22.4%), the United States (30.9%), North America (3.7%), China (8.4%), Asia/Pacific (10.2%), Brazil (10.5%) and Latin America (7.8%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
20
Last Close Price
28.42 EUR
Average target price
37.6 EUR
Spread / Average Target
+32.30%
Consensus
  1. Stock
  2. Equities
  3. Stock Bayer AG - Xetra